| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872dd7cd609eb2a937dcfd303d521798 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a160d333694ee6e355d889911d5b37b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b5febea58ed8c1439a60c4e09bed17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d63e5e293f00cdfe463525431e3505e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58908f6d1d62d9288a5cf32c82f9b94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49f3900c20bb8ec1783493fb28613115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c9986690d75dc9e63e0e71f4499cb07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f69852f726fc3b384d29c1f451aa724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbbe6f544111abe7178bb4059c184482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b994ac801acda8371009bb73dd55fef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc82a21c8e1de3e9f84a521ab4eeb106 |
| publicationDate |
2019-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112019011388-A2 |
| titleOfInvention |
combination therapy |
| abstract |
The present invention provides a combination of an arginine methyltransferase type i (prmt type i) inhibitor and an arginine methyltransferase type ii protein (prmt type ii) inhibitor. The present invention also provides methods for treating cancer in a human in need thereof, methods comprising administering to the human a combination of a type II prmt inhibitor and a type II prmt inhibitor, together with at least one of: a carrier pharmaceutically acceptable and a pharmaceutically acceptable diluent thereby treating cancer in humans. The present invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a type II prmt inhibitor and a second pharmaceutical composition comprising a therapeutically effective amount of a type II prmt inhibitor. |
| priorityDate |
2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |